Universität zu Köln

2023

Pozios, Ioannis ORCID: 0000-0002-3462-9822, Hering, Nina A., Guenzler, Emily, Arndt, Marco, Elezkurtaj, Sefer, Knosel, Thomas, Bruns, Christiane J., Margonis, Georgios A., Beyer, Katharina and Seeliger, Hendrik ORCID: 0000-0002-5937-052X (2023). Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144. J. Cancer Res. Clin. Oncol., 149 (1). S. 271 - 281. NEW YORK: SPRINGER. ISSN 1432-1335

2022

Lee, Lucas D. ORCID: 0000-0001-5729-0537, Pozios, Ioannis ORCID: 0000-0002-3462-9822, Liu, Verena, Nachbichler, Silke B., Boehmer, Dirk, Kamphues, Carsten ORCID: 0000-0002-5406-8540, Beyer, Katharina, Bruns, Christiane J., Kreis, Martin E. ORCID: 0000-0002-9312-4840 and Seeliger, Hendrik ORCID: 0000-0002-5937-052X (2022). Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma. Radiat. Environ. Biophys., 61 (2). S. 255 - 263. NEW YORK: SPRINGER. ISSN 1432-2099

2018

Pozios, Ioannis, Knoesel, Thomas, Zhao, Yue, Assmann, Gerald, Pozios, Iraklis, Mueller, Mario H., Bruns, Christiane J., Kreis, Martin E. and Seeliger, Hendrik (2018). Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma. J. Cancer Res. Clin. Oncol., 144 (10). S. 1887 - 1898. NEW YORK: SPRINGER. ISSN 1432-1335

Seeliger, Hendrik, Pozios, Ioannis, Assmann, Gerald, Zhao, Yue, Mueller, Mario H., Knoesel, Thomas, Kreis, Martin E. and Bruns, Christiane J. (2018). Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma. BMC Cancer, 18. LONDON: BMC. ISSN 1471-2407

2017

Zhao, Yue, Altendorf-Hofmann, Annelore, Pozios, Ioannis, Camaj, Peter, Daeberitz, Therese, Wang, Xiaoyan, Niess, Hanno, Seeliger, Hendrik, Popp, Felix, Betzler, Christopher, Settmacher, Utz, Jauch, Karl-Walter, Bruns, Christiane and Knoesel, Thomas (2017). Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma. J. Cancer Res. Clin. Oncol., 143 (6). S. 1061 - 1069. NEW YORK: SPRINGER. ISSN 1432-1335